Brunei Darussalam

Reimbursed Care Access

Brunei Darussalam maintains a strict, prohibition-oriented regime for narcotics and psychotropic substances under the Misuse of Drugs Act (and associated regulations). Most classic psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X, ibogaine, ayahuasca) are controlled with no authorized medical use outside approved research; ketamine is a controlled medicine used in clinical settings as an anaesthetic but psychedelic/psychiatric uses are off-label and not reimbursed or widely authorised. There is no public reimbursement pathway for psychedelic-assisted therapies in Brunei as of today; activities involving these substances risk severe criminal penalties under national law.